Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Organization National Institutes of HealthPosted 18 Nov 2024Deadline 7 Sept 2026
HHS-NIH1193.12193.86693.17293.393synopsis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Opportunity Number: PAR-25-096 Document Type: synopsis CFDA Numbers: 93.121, 93.866, 93.172, 93.393

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →